In the present study, we confirmed that IR and temozolomide increased the CDK5 activity and that TP5 alone or in combination increased DNA-damage on glioblastoma cells and impaired their ability to repair DNA damage by reducing ATM phosphorylation, which is consistent with previous observations on other cancer cell lines. Here, ATM is linked to glioblastoma.